{"schema_version":"1","generated_at":"2026-11-01T10:44:31.197Z","data_as_of":null,"url":"https://www.findmykol.com/kol/rabih-said","json_url":"https://www.findmykol.com/kol/rabih-said/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"rabih-said","name":"Rabih Said","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1235451261","openalex":"A5111343463"},"summary":"Rabih Said is an Oncology physician. OpenAlex indexes 57 publications with 587 citations (h-index 12); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":57,"cited_by_count":587,"h_index":12,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT02452281","title":"Pilot Study to Evaluate the Effects of a Vaccine (HSPPC-96) Combined With Ipilimumab in Patients With Advanced Melanoma","phase":"PHASE1/PHASE2","status":"WITHDRAWN","role":"Overall official","sponsor":"Rabih Said","source_url":"https://clinicaltrials.gov/study/NCT02452281","trial_url":"https://www.findmykol.com/trial/NCT02452281"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":2,"shown":2,"withheld":0,"rows":[{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2023,"amount_usd":20,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1235451261"},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2022,"amount_usd":42.11,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1235451261"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1235451261","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids","year":2025,"journal":"SLAS DISCOVERY","source_url":"https://doi.org/10.1016/j.slasd.2025.100222","status":"verified"},{"title":"CTEP 10492, a phase 1/1b study of the AKT inhibitor ipatasertib with chemoradiation for locally advanced head and neck squamous cell carcinoma.","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.tps6127","status":"verified"},{"title":"Abstract CT042: NCI10217: Phase Ib biomarker-driven tumor-agnostic combination (Combo) trial of copanlisib (Copa) and olaparib (Ola) in molecularly-selected patients (pts) with advanced cancers with PIK3CA hotspot, PTEN and DNA damage response (DDR) mutations","year":2024,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.am2024-ct042","status":"verified"},{"title":"Abstract PO1-06-14: Preliminary results of a phase I dose escalation study of eribulin in combination with copanlisib in patients with metastatic triple negative breast cancer (TNBC)","year":2024,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.sabcs23-po1-06-14","status":"verified"},{"title":"Abstract PS17-06: A phase I trial of the PI3K inhibitor (PI3Ki) copanlisib and fulvestrant in combination with continuous or intermittent abemaciclib in patients with estrogen receptor-positive (ER+), HER2-negative (HER2-) metastatic breast cancer","year":2024,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.sabcs23-ps17-06","status":"verified"}],"source":"works"},"contact":{"address_1":"6400 FANNIN ST","address_2":"2900","city":"Houston","state":"TX","zip":"770301521","phone":"713-704-3010","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1235451261","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2013-10-07","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}